COVID-19 Booster for Children Ages 5-11 in Laredo

Translate to Spanish or other 102 languages!

 The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes
The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas – The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. 

Pfizer’s clinical trial showed that a booster dose of the Pfizer-BioNTech COVID-19 Vaccine prompted a robust immune response in this age group, generating neutralizing antibodies against the SARS-CoV-2 virus regardless of prior SARS-CoV-2 infection. The actions taken by the FDA would make all Americans 5 and older eligible for a booster shot.

“FDA/CDC pediatric booster approval ensures a higher level of COVID-19 protection amongst children over the summer and when returning to school in the fall,” says Dr. Richard Chamberlain, Health Director, “We continue to urge our community to get vaccinated; vaccines work, vaccines are safe, and vaccines save lives. Stay up-to-date with your vaccines”.

- Advertisement -

The City of Laredo Health Department will provide COVID-19 boosters shots to children 5-11 years of age starting Friday, May 20, 2022. Vaccines will be available at the City of Laredo Health Department Clinic located at 2600 Cedar Ave. or across the city of Laredo via our Mobile Health Clinic

For more information or updates, please follow our social media channels at @LaredoHealth or call (956) 236-8311.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

STHS Clinics Surgeon Dr. Miguel Rodriguez Earns Prestigious National Recognition

Miguel Rodriguez, DO, FACS, a general, robotic and bariatric surgeon with STHS Clinics, has been inducted as a Fellow of the American College of Surgeons (ACS), earning the prestigious FACS designation.

AACT Now Launches Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, or AACT Now, launched its Rally the Vote initiative Thursday, bringing together community organizations and regional leaders to expand access to nonpartisan voter information across the Rio Grande Valley.

Healthcare Alliance Recognizes Texas Oncology Investment in Valley Cancer Care

Maritza Gonzalez, founder and director of the Texas Healthcare Alliance Chamber of Commerce, recognized Texas Oncology’s continued investment in Rio Grande Valley cancer care during the Sept. 29 grand opening of the Texas Oncology McAllen West clinic.
- Advertisement -